Biologically active fragments of glucagon-like insulinotropic peptide
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 12, 1996
Grant Date -
N/A
app pub date -
Aug 30, 1994
filing date -
Aug 30, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
N-terminal truncated forms of glucagon like insulinotropic peptide (GLP-1) and analogs thereof are provided. The claimed polypeptides promote glucose uptake by cells but do not stimulate insulin expression or secretion. The invention also provides methods for treating diabetes and pharmaceutical formulations comprising the claimed polypeptides.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully